Skip to content
Dosage GuideResearch Reference

CNTF Peptide Dosage

Research-based dosing protocols, timing guidance, and reconstitution reference for CNTF Peptide. All information is for educational purposes only.

Quick Answer

Dosing of CNTF-derived peptides is still largely experimental. Preclinical studies use a wide range of doses (mcg to mg/kg), with limited human data available. Subcutaneous, intranasal, and oral routes have been explored in animal models.

→ CNTF Peptide Benefits→ CNTF Peptide Side Effects→ Full CNTF Peptide Profile
Table of Contents

Standard Dosage Range

Research dosing range: Variable; 100 mcg - 1 mg (animal models); Human dosing unclear.

Educational reference only

These dosage ranges are derived from preclinical research and community protocols. No human clinical dose-ranging trials have established therapeutic doses for most research peptides. Always consult a qualified healthcare provider before starting any peptide protocol.

Dosage by Use Case

Neuroprotection (experimental)

100–500 mcg1–2× daily
Duration

4–12 weeks

Based on animal models. Subcutaneous or intranasal administration. Monitor for potential side effects.

Motor Neuron Disease (ALS, experimental)

200 mcg - 1 mg1× daily
Duration

Variable

Limited human data. Animal studies suggest potential benefits. Consult with a qualified healthcare professional.

Cognitive Enhancement (experimental)

100-300 mcg1x daily
Duration

4-8 weeks

Based on preclinical animal data. Monitor for cognitive and mood changes

Timing & Frequency

Timing varies based on the peptide fragment and route of administration. Intranasal administration may provide faster onset. Subcutaneous injections can be administered morning or evening.

Cycle Guidance

Given limited human data, conservative cycling (e.g., 8 weeks on, 4 weeks off) is prudent. Monitor for any adverse effects during and after the cycle.

Reconstitution Reference

Quick reference for reconstituting CNTF Peptide. For custom vial sizes and concentrations, use the Reconstitution Calculator.

Common Vial SizeTypically 1-5 mg per vial
BAC Water Volume1-2 mL bacteriostatic water for 1-5 mg/mL concentration
Concentration & DrawAt 1 mg/mL: 100 mcg = 0.1 mL (10 units on a 100-unit insulin syringe)
StorageRefrigerate at 2–8°C after reconstitution. Keep lyophilized powder at room temperature or refrigerated.
StabilityReconstituted solution stable up to 30 days refrigerated. Lyophilized powder stable 12-24 months per manufacturer specifications.
Use the Reconstitution Calculator → for precise injection volumes based on your exact vial size, water volume, and desired dose.

Frequently Asked Questions

What is the optimal dosage of CNTF peptide?
Optimal dosage is currently unknown due to limited human studies. Preclinical research suggests a wide range of doses (mcg to mg/kg) may be effective, depending on the target condition and specific peptide fragment.
What is the best route of administration for CNTF peptide?
Subcutaneous, intranasal, and oral routes have been explored in animal models. Intranasal administration may offer faster onset. The optimal route depends on the specific peptide fragment and its bioavailability.
Are there any known side effects of CNTF peptide?
Side effects are not well-characterized in humans. Full-length CNTF has been associated with weight loss and antibody formation in clinical trials. Monitor for any adverse effects during experimental peptide use, and discontinue if necessary.

Last updated: 2026-02-19